Microsoft Word - S_2019_GRC-02_025_S43 Share Acquisition_EN Page 1 – Translation – GRC-02/2019/025 11 December 2019 Subject: Report of the Asset Acquisition To: President The Stock Exchange of
21.00 34.02% Administrative expenses 35.21 32.44 2.77 8.54% Financial costs 0.45 0.02 0.43 2,150.00% Share of profit (loss) of associates (0.17) (0.17) 0 0.00% Profit before income tax expenses 42.15
as multivitamin, PreBo products (holistic nutrients for bone), YUUU toothpaste, etc. The company has cancelled the sales of Nabota in Business Unit of Aesthetic Innovation products around the end of
2019, largely from sales of botulinum toxin products and symbiotic products such as multivitamin, PreBo products (holistic nutrients for bone), YUUU toothpaste, etc. Other Revenues Other revenues
2019, largely from sales of botulinum toxin products and symbiotic products such as multivitamin, PreBo products (holistic nutrients for bone), YUUU toothpaste, etc. Other Revenues Other revenues
by sales of probiotics products i.e. Probac, PreBo products (holistic nutrients for bone), multivitamin products (Multivitamin), sanitizing hand gel and YUUU toothpaste, etc. In addition, there was
, AXS, BADGER, BAKE, BAND, BETA, BFC, BICO, BNB, BOND, BONE, BORA, BSW, BTCST, BTRST, C98, CAKE, CEEK, CELR, CFX, CHR, CHZ, CLV, COTI, CRO, CRV, CTSI, CVC, CVX, DAR, DCR, DENT, DEXE, DFI, DGB, DIA, DOGE
, ASD, AUDIO, AXS, BADGER, BAKE, BAND, BETA, BFC, BICO, BNB, BOND, BONE, BORA, BSW, BTCST, BTRST, C98, CAKE, CEEK, CELR, CFX, CHR, CHZ, CLV, COTI, CRO, CRV, CTSI, CVC, CVX, DAR, DCR, DENT, DEXE, DFI, DGB
, BCH, BDX, BEL, BETA, BGB, BICO, BLOK, BLUR, BLZ, BMX, BNT, BNX, BOBA, BONE, BORA, BOSON, BRISE, BSV, BSW, BTC, BTCB, BTG, BTT, BUSD, C98, CAKE, CBK, CCD, CEEK, CELO, CELR, CFG, CFX, CGPT, CHR, CHZ, CKB
/ appointing date) 1. ผูจัดทํา / Reporter หุนสามัญ (Common share) หุนบุริมสิทธิ (Preferred share) ใบสําคัญแสดงสิทธิที่จะซื้อหุน (Warrant) หุนกูแปลงสภาพ (Convertible debenture) หุนสามัญ (Common share) หุ